Cargando…
Squamous cell carcinomas of the skin responsive to erlotinib: 5 cases
Autores principales: | Read, William L., Brumund, Kevin T., Weisman, Robert A., Nguyen, Angel Q. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4808694/ https://www.ncbi.nlm.nih.gov/pubmed/27051715 http://dx.doi.org/10.1016/j.jdcr.2015.02.014 |
Ejemplares similares
-
Sustained complete response to erlotinib in squamous cell carcinoma of the head and neck: A case report
por: Thinn, Mie Mie, et al.
Publicado: (2019) -
Recombinant human erythropoietin promotes the acquisition of a malignant phenotype in head and neck squamous cell carcinoma cell lines in vitro
por: Abhold, Eric, et al.
Publicado: (2011) -
Long Term Survivor with Erlotinib in Metastatic Lung Cancer-Squamous Cell Carcinoma Subtype
por: VATU, BOGDAN IONEL, et al.
Publicado: (2020) -
Stability and Formulation of Erlotinib in Skin Creams
por: Nguyen, David, et al.
Publicado: (2022) -
Excellent response to erlotinib in breast carcinoma with rare EGFR mutation—a case report
por: Singh, Gunjesh Kumar, et al.
Publicado: (2020)